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Objectives: Kashin-Beck disease (KBD) is a disabling osteoarthropathy involving growth cartilage endemic
to selenium (Se)-deﬁcient regions in China. Associations between genetic variation in selenoprotein
genes and susceptibility to many diseases have recently been investigated but few studies have been
performed on KBD. We found four genetic polymorphisms in selenoprotein genes and assessed their
association with increased susceptibility to KBD.
Methods: Four polymorphisms including GPX1 (rs1050450), TrxR2 (rs5748469), SEPP1 (rs7579) and DIO2
(rs225014) were analyzed for 161 KBD patients and 312 controls using polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP) or tetra-primer ampliﬁcation refractory mutation
system PCR (Tetra-primer ARMS PCR). Glutathione peroxidase (GPX) activity in whole blood was
measured using a GPX assay kit. The mRNA expression of GPX1, nuclear factor-kB (NF-kB) p65 and p53 in
both whole blood and articular cartilage tissue were detected using Real-Time PCR.
Results: The genotypic and allelic frequency of GPX1 Pro198Leu was signiﬁcantly different between
KBD patients and controls (P¼ 0.013, P¼ 0.037). A signiﬁcant increased KBD risk was observed in
individuals with Pro/Leu or Leu/Leu (odds ratio¼ 1.781; 95% conﬁdence interval: 1.127e2.814)
compared with Pro/Pro. No association was observed between the other three single nucleotide
polymorphisms (SNPs) and KBD risk. In addition, GPX enzyme activity in whole blood was lower in the
KBD group (P< 0.01), and the GPX activity in whole blood decreased signiﬁcantly in a subgroup of
individuals representing Pro/Leu and Leu/Leu compared to Pro/Pro (P< 0.01). In whole blood and
articular cartilage tissue samples of KBD patients, GPX1 and NF-kB p65 mRNA levels were lower
(P< 0.01) while p53 levels were higher (P< 0.001).
Conclusion: GPX1 Pro198Leu is a potential genetic risk factor in the development of KBD and the GPX1
Leu allele is signiﬁcantly associated with higher KBD risk among the Chinese Han population and with
lower GPX enzyme activity. The expression of apoptosis related molecules in KBD patients signiﬁcantly
differs from controls.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Kashin-Beck disease (KBD) is a disabling osteoarthropathy
involving growth cartilage that is endemic to certain areas ofWeijin Zang, Department of
niversity, No. 76 Yanta West
-29-82655150; Fax: 86-29-
s Research Society International. PChina, south-east Siberia and North Korea1,2. The disease mainly
affects children or teenagers, causing symmetrical thickening and
deformity of joints of limbs which ﬁnally results in disturbed
skeletal development. One of the most typical pathological char-
acteristics of KBD is chondrocyte apoptosis and necrosis3,4.
Although its etiopathogenesis is still obscure, epidemiological
studies demonstrate KBD is mainly common in low selenium (Se)
areas where patients are in a Se-deﬁcient condition. Furthermore,
Se supplementation was effective in preventing a worsening of
metaphysis change and in promoting repair5. Therefore, Seublished by Elsevier Ltd. All rights reserved.
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causing KBD6,7. However, KBD is focally distributed and shows
a clustering of disease in families8, and there is no KBD in some low
Se areas such as Yunnan province in China and in Finland.
Furthermore, Se supplementation could not entirely prevent KBD.
These suggest that Se is not the only causative agent of KBD and
that there must be some additional mechanism playing a role in
KBD development.
Some susceptibility genes might lead to changes in suscepti-
bility to environmental factors such as Se deﬁciency or other bio-
logic factors. It is likely that many of the effects of Se are mediated
through its role as a constituent of Se-containing proteins9. Sele-
noproteins contain the unusual selenocysteine amino acid residue
incorporated by a speciﬁc tRNA. Ablation of this tRNA in mice
results in chondronecrosis and abnormal skeletal development
reminiscent of KBD10. Also, Ebert et al. have found selenoproteins
were important in bonemetabolism as Se deﬁciencywas associated
with osteoarthropathy in humans11. In the present study, we
selected the four selenoproteins [e.g., glutathione peroxidases
(GPXs), thioredoxin reductases (TrxRs) and selenoprotein P (SEPP)]
responsible for antioxidative defense12 and maintaining a circu-
lating level of thyroid hormone and regulation of bone metabo-
lism13 [e.g., deiodinase (DIO) family] to identify susceptibility genes
for KBD. In addition to its antioxidant and bone metabolism regu-
lating effects, these selenoproteinsmay be involved in cell signaling
and reducing inﬂammatory processes14. It has been reported that
the cartilage degeneration and apoptosis induction pathwaysmight
be more important in KBD chondronecrosis15. Some studies have
demonstrated that p53 plays an important role in initiating
apoptosis and that p53 gene expression is modulated by nuclear
factor-kB (NF-kB) p65.
It is important to study genetic variations of the selenoproteins
that result in enhanced susceptibility to oxidative stress. Compel-
ling evidence suggests there is an association between variants of
the selenoprotein genes and an increased risk of cancer and other
diseases16e19, but few studies have been performed on the rela-
tionship between selenoprotein gene polymorphisms and osteo-
arthropathy risk. Given these ﬁndings, it is of great interest to study
the association between gene polymorphisms in selenoproteins
and susceptibility to KBD. We conducted a caseecontrol study to
explore the associations between KBD risk and four selenoprotein
genetic polymorphisms [GPX1 (rs1050450), TrxR2 (rs5748469),
SEPP1 (rs7579) and DIO2 (rs225014)] in a Chinese Han population
which had not been previously studied. Furthermore, we also
investigated GPX activity and mRNA expressions of GPX1, NF-kB
p65 and p53. It is hoped that this study would help us screen for
KBD susceptible genes and understand the molecular mechanism
of chondrocyte apoptosis and necrosis in KBD.Table I
Conditions used for genotyping assays
SNPs Primers*
GPX1 (rs1050450) Fw: 50-TCCAGACCATTGACATCGAG-30
Rv: 50-ACTGGGATCAACAGGACCAG-30
TrxR2 (rs5748469) Fw: 50-GGCTGAAGGACTTTGGTGTC-30
Rv: 50-CCCACACTCTTCTGGACCTC-30
SEPP1 (rs7579) Fw(inner): 50-TGACCTTCAAACTAAATATT
Rv(inner): 50-TGTGTCTAGACTAAATTGGG
Fw(outer): 50-GAGGAGAACATAACTGAAT
Rv(outer): 50-CTCCATCATAAAAAATATGG
DIO2 (rs225014) Fw: 50-GATAGTAAAGAATAACAGCCTTGG
Rv: 50-CAGCTATCTTCTCCTGGATACCA-30
Ta, annealing temperature; Res, restriction enzymes.
* All Primers used in this study were synthesized by Shanghai Sangon Biological EngiMaterial and methods
Study population
According to the national diagnostic criteria of KBD of China (GB
16003-1995), 161 patients were enrolled in the study based on
radiography examination (X-ray of the right hand) and clinical
diagnosis (degree IeIII) from six counties in KBD endemic areas
(Xunyi, Linyou, Yongshou, Qianyang, Long and Changwu counties).
A total of 312 healthy subjects with no signs or symptoms of
arthritis or joint disease from Xi'an city were randomized to serve
as a control group and were frequency matched by age and sex. All
subjects in this study were Han Chinese and resided in Shaanxi
Province, P.R. China. The study was performed in accordance with
the Declaration of Helsinki and approved by the Human Ethics
Committee of Xi'an Jiaotong University, P.R. China. Informed
written consent was obtained from each subject.
Sample collection
Fresh blood (5 mL) was collected from the antecubital vein of all
subjects in the fasting state. The blood samples were used for
measurement of GPX activity in whole blood and for isolation of
DNA and RNA. Articular cartilage tissue was obtained from knee
joints from a total of nine KBD patients in excision of corpus lib-
erum and three control subjects during joint replacement surgery
and immediately snap-frozen in liquid nitrogen and stored at
70C until analyzed.
Genotyping analysis
DNA was isolated from peripheral blood lymphocytes using
classical phenol/chloroform extraction. Four polymorphic variants
of GPX1 (rs1050450), TrxR2 (rs5748469), SEPP1 (rs7579) and DIO2
(rs225014) were identiﬁed using PCR-restriction fragment length
polymorphism (PCR-RFLP) and tetra-primer ampliﬁcation refrac-
tory mutation system PCR (Tetra-primer ARMS PCR). Primers,
annealing temperature and restriction endonucleases used in the
study are listed in Table I. The reaction details are as follows:
The GPX1 (rs1050450) polymorphism was determined by PCR-
RFLP using an Eppendorf gradient type mastercycler (Eppendorf,
Germany) with a total volume of 12.5 mL, containing 6.25 mL 2 Taq
PCR MasterMix, 0.5 mL each primer (10 mM), 1.5 mL genomic DNA
and 3.75 mL H2O. The reaction conditions were: initial denaturation
at 94C for 3 min, followed by 35 cycles of denaturation at 94C for
30 s, annealing at 58C for 30 s and extension at 72C for 30 s, and
a ﬁnal elongation step at 72C for 5 min. The ampliﬁcation products
were digestedwith Apa I restriction endonuclease (Fermentas, MBI,Ta (C) REs
58 Apa I
65 BsuR I
TAAAATCGG-30 58 e
GAGTATTTT-30
CTTGTCAGT-30
TTTGAGTC-30
CT-30 58 Afa I
neering Technology & Services Co. Ltd (Shanghai, China).
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modiﬁcation.
The TrxR2 (rs5748469) polymorphism was genotyped by
PCR-RFLP with a total volume of 30 mL, containing 0.12 mL Taq
polymerase (5 U/mL), 3.0 mL 10 PCR Buffer, 1.8 mL Mg2þ (25 mmol/
L), 0.6 mL dNTP (10 mmol/L each), 0.18 mL each primer (100 mmol/L),
3 mL genomic DNA and 21.12 mL H2O. The reaction conditions were
as follows: initial denaturation at 94C for 5 min followed by 30
cycles of denaturation at 94C for 30 s, annealing at 65C for 30 s
and extension at 72C for 30 s, and with a ﬁnal elongation step at
72C for 10 min. The ampliﬁcation products were digested with
BsuR I restriction endonuclease (New England Biolabs, China).
The genotyping of SEPP1 (rs7579) was performed using Tetra-
primer ARMS PCR assay and both pairs of primers were used in the
same PCR reaction. A 338 bp product was used as a control for
success of the ampliﬁcation using two outer primers which were
also used for pairing with the inner primers to selectively generate
the corresponding polymorphism product. PCR was carried out
with a total volume of 12.5 mL, containing 6.25 mL 2 Taq PCR
MasterMix, 0.5 mL each primer (10 mM), 1.5 mL genomic DNA and
2.75 mL H2O. Thermocycling were the same as for GPX1
(rs1050450).
The DIO2 (rs225014) polymorphism was determined by PCR-
RFLP. The PCR reaction was the same as for GPX1 (Pro198Leu). The
ampliﬁcation products were digested with Afa I restriction endo-
nuclease (Takara, Japan).
DNA fragments were separated by 2% agarose electrophoresis
stained with 0.5 mg/mL ethidium bromide and visualized with
a Light Transilluminator (UVP, USA). In addition, about 20% of the
DNA samples were randomly selected for re-genotyping.
GPX activity assays
The total GPX activity in whole blood was measured using the
GPX assay kit (Nanjing Jiancheng Bio-Tek Co., Nanjing, China)
according to manufacturer's instructions. OD values were recorded
at 412 nm on a model 752 ultraviolet and visible spectrophotom-
eter (Beijing, China). One activity unit was deﬁned as the concen-
tration which consumed at 1 mmol/L of glutathione (GSH) in the
reaction system per 4 mL whole blood reacted at 37C for 5 min
after subtracting non-enzymatic reaction.
Quantitative Real-Time PCR
A total of 24 blood samples and 12 articular cartilage samples
were collected for mRNA quantiﬁcation of GPX1, NF-kB p65 and
p53 respectively. Total RNA was isolated from 3 mL whole blood or
100 mg articular cartilage tissues respectively using TRIzol reagent
(Invitrogen, USA) according to the manufacturer's instructions.
Total RNAs were reverse transcribed using the RevertAidTM First
Strand cDNA Synthesis Kit (Fermentas, MBI, Lithuania) according to
manufacturer's instructions in the thermocycler to obtain the ﬁrst
strand cDNA.
The mRNA quantiﬁcation of GPX1, NF-kB p65 and p53 was
performed on iQ5 Real-Time PCR Detection Systems (Bio-Rad,
USA) using BioEasy SYBR Green I Real-Time PCR Kit (Bioer,Table II
List of sequences of primers used in Real-Time PCR
Genes Forward
GPX1 50-CGCTTCCAGACCATTGACATC-30
NF-kB p65 50-CGCATCCAGACCAACAACAACC-30
p53 50-TGCGTGTGGAGTATTTGGATGAC-
b-actin 50-GAACGGTGAAGGTGACAGCAG-30Hangzhou, China) according to manufacturer's instructions.
Ampliﬁcation primers are shown in Table II. Reactions were per-
formed in a 25 mL mixture containing 2 mL cDNA, 0.5 mL each primer
(10 mM), 12.5 mL 2 SYBR Mix (with 4.0 mMMg2þ), 0.15 mL Taq DNA
Polymerase and 9.35 mL ddH2O under the conditions of initial
denaturation at 94C for 2 min, followed by 40 cycles of denatur-
ation at 94C for 10 s, annealing at 61C for 15 s and extension at
72C for 30 s. All reactions were performed in duplicate. Results
were normalized with total levels of b-actin expression and
analyzed by iQ5 software (version 2.0, Bio-Rad, USA) and SPSS
13.0.
Statistical analysis
Quantitative data was expressed as mean standard deviation
(SD). The distribution normality was analyzed using the Kolmo-
goroveSmirnov test. Differences without skewness between the
KBD and control groups were assessed by Student's t-test
(two tailed). Differences of measurement data departing from
normal distribution between two groups were analyzed with the
ManneWhitney U-test. Categorical variables were presented using
frequency counts and compared by a c2-test. Deviation from
HardyeWeinberg equilibriumwas analyzed by a c2 goodness-of-ﬁt
test. Odds ratio (OR) and 95% conﬁdence interval (CI) were calcu-
lated as an estimate of risk. P< 0.05 was considered statistically
signiﬁcant. All statistical analyses were performed with SPSS 13.0
software.
Results
Baseline characteristics
A total of 161 KBD patients and 312 frequency age and sex
matched controls were included in this study. No signiﬁcant
differences were observed between KBD and control group in age
(52.2 6.2 vs 52.0 6.1, P¼ 0.717) and sex (male/female, 86/75 vs
157/155, P¼ 0.523). In addition, the clinical stages of the 161 KBD
patients were divided into I, II and III. The baseline characteristics
are shown in Table III.
Genotype analysis
In this study, four single nucleotide polymorphisms (SNPs) were
genotyped by PCR-RFLP and ARMS-PCR. Agarose gel electropho-
retograms for polymorphism analysis are shown in Fig. 1. The elec-
trophoresis bandswere clear and the brightnesswas uniform in Fig.1
by which different genotypes could be discerned. All of the SNP
genotype frequencies in the study were in HardyeWeinberg equi-
librium (P> 0.05). The genotypic and allelic distribution of GPX1
(rs1050450,Pro198Leu), TrxR2 (rs5748469), SEPP1 (rs7579) andDIO2
(rs225014) are presented inTable IV. The results show that Pro198Leu
of GPX1 displayed signiﬁcant differences in genotypic and allelic
frequency between the KBD and control groups. The other three SNPs
detected were not signiﬁcantly different from control. The frequency
of variant genotypes, the 198Pro/Leu heterozygote and the 198Leu/
Leu mutant homozygote, in KBD cases (27%) was signiﬁcantly higherReverse
50-CGAGGTGGTATTTTCTGTAAGATCA-30
50-AGAGCCGCACAGCATTCAGG-30
30 50-CAGTGTGATGATGGTGAGGATGG-30
50-GTGGACTTGGGAGAGGACTGG-30
Table III
Characteristics of the study population
Characteristics Cases (n¼ 161) Controls (n¼ 312) P
Age, mean SD 52.2 6.2 52.0 6.1 0.717*
Sex, male/female 86/75 157/155 0.523y
Degree
I 27 e e
II 41 e e
III 93 e e
* The comparison between two groups was performed using t-test and no
signiﬁcance.
y The comparison between two groups was performed using c2-test and no
signiﬁcance.
Table IV
Genotype and allele frequencies of polymorphisms across selenoprotein genes
between KBD and control groupy
SNPs Controls, n (%) KBD, n (%) P OR (95%CI)**
GPX1 (rs1050450)z
CC 259 (83) 118 (73) 1.000 (e)
CT 50 (16) 43 (27) 0.013* 1.781 (1.127e2.814)
TT 3 (1) 0
C-allele 568 (91) 279 (87) 0.037* 1.000 (e)
T-allele 56 (9) 43 (13) 1.563 (1.025e2.385)
TrxR2 (rs5748469)z
AA 81 (74) 70 (83) 1.000 (e)
AC 28 (26) 13 (16) 0.132 0.579
CC 0 1 (1) (0.283e1.185)
A-allele 190 (87.2) 153 (91.1) 0.225 1.000 (e)
C-allele 28 (12.8) 15 (8.9) 0.665 (0.343e1.290)
SEPP1 (rs7579)
GG 98 (59) 82 (50.9) 1.000 (e)
GA 53 (31.9) 65 (40.4) 0.272 1.466 (0.919e2.337)
AA 15 (9.1) 14 (8.7) 1.115 (0.509e2.446)
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codon 198 of GPX1 among KBD cases was signiﬁcantly higher than
that in control group (13% and 9%, respectively, P¼ 0.037). The
distributions of genotype and allele of GPX1198Pro/Leu in differentFig. 1. Agarose gel electrophoretograms for polymorphism analysis. (A) PCR fragment of
GPX1 was digested with Apa I (GGGCCC). The 222 bp PCR product was cleaved into two
fragments of 170 and 52 bp in the presence of CC homozygous, three fragments of 222,
170 and 52 bp for CT heterozygote (the 52 bp fragment is typically not visible on the
gels), while the TT homozygous remained uncleaved showing only the 222 bp PCR
product. (B) The PCR-ampliﬁed fragment of TrxR2was subjected to digestionwith BsuR I
(GGCC). The 254 bp PCR productwas cleaved into two fragments of 209 and 45 bp for AA
genotype, four fragments of 209, 122, 87 and 45 bp for AC genotype, while 122, 87 and
45 bp for CC genotype (the 45 bp fragment is typicallynot visible on the gels). (C) The PCR
product of SEPP1 is 338 bp in length. Two fragments of 338 and 213 bp for GG genotype,
three fragments of 338, 213 and 183 bp for GAheterozygote,while 338 and 183 bp for AA
genotype. (D) PCR fragment of DIO2 was subjected to digestion with Afa I (GTAC). The
412 bp PCR product was cleaved into 363 and 49 bp fragments for TT, three fragments of
412, 363 and 49 bp for CT heterozygote (the 49 bp fragment is typically not visible on the
gels), whereas the CC genotype remained uncut. M, molecular size marker. P, PCR
product. PCR fragments were separated on 2% agarose gels.
G-allele 249 (75) 229 (71.1) 0.263 1.000 (e)
A-allele 83 (25) 93 (28.9) 1.218 (0.862e1.722)
DIO2 (rs225014)
TT 64 (30.6) 48 (29.8) 1.000 (e)
TC 106 (50.7) 78 (48.5) 0.761 0.981 (0.610e1.578)
CC 39 (18.7) 35 (21.7) 1.197 (0.663e2.159)
T-allele 234 (56) 174 (54) 0.598 1.000 (e)
C-allele 184 (44) 148 (46) 1.082 (0.808e1.449)
* represents signiﬁcance at P< 0.05.
y The comparison of genotype and allele frequency between two groups was
performed using c2-test.
z The variant genotypes of GPX1 (rs1050450, CT and TT) and TrxR2 (rs5748469,
AC and CC) were ascribed to a single group respectively during c2-test.
** 95%CI, 95% conﬁdence interval.subgroupsof age, sex and clinical stageswere further analyzed inKBD
cases. Results showed that there were no signiﬁcant differences of
genotype distribution in different subgroups (P¼ 0.437, 0.468 and
0.992 for age, sex and clinical stages, respectively) and no signiﬁcant
differences were observed for allele frequency (P¼ 0.506, 0.505 and
0.993, respectively). It is suggested that the genotypic and allelic
frequency of KBD group were not inﬂuenced by age, sex or clinical
stage (data not shown).
However, no signiﬁcant differences were found in genotypic and
allelic frequency of the SNPs of TrxR2 (rs5748469), SEPP1 (rs7579)
and DIO2 (rs225014) between KBD and control group (Table IV).
The possible associations between polymorphisms in seleno-
protein genes and KBD risk were estimated by calculating OR and
95%CI (Table IV). The results showed there was a 1.781-fold (95%CI:
1.127e2.814) increased risk of KBD for individuals with at least one
variant allele (Pro/Leu or Leu/Leu genotype) compared with
homozygous wild-type individuals (Pro/Pro). In addition, individ-
uals with the variant T-allele (Leu) for this SNP had a 1.563-fold
(C-allele is referent, 95%CI: 1.025e2.385) increased risk of KBD.
These data suggested that Pro198Leu of GPX1 was signiﬁcantly
associated with an increased risk of KBD. However, ORs and 95%CIs
data indicated there were no signiﬁcant associations of TrxR2
(rs5748469), SEPP1 (rs7579) and DIO2 (rs225014) with KBD risk.GPX activity
The results for the GPX activity of whole blood are shown in
Fig. 2. TheGPXactivitieswere176.3612.45 Uand199.2311.49 U
for KBD and control group respectively. The difference was signiﬁ-
cantly different (P< 0.01) between the two groups. Furthermore,
when subdivided by GPX1 Pro198Leu genotype, the GPX activity in
Fig. 2. The enzyme activity of GPX in whole blood of KBD (n¼ 15) and control group
(n¼ 25). The GPX activity was lower in KBD than that in control group (176.3612.45
and 199.2311.49 U, respectively, P< 0.01). * represents signiﬁcance at P< 0.01.
Y.M. Xiong et al. / Osteoarthritis and Cartilage 18 (2010) 817e824 821whole blood decreased signiﬁcantly in the subgroup of individuals
representing Pro/Leu and Leu/Leu compared to Pro/Pro (P< 0.01).mRNA expression of GPX1, NF-kB p65 and p53
GPX1 mRNA level was determined by Real-Time PCR. b-actin
cDNA was the reference in all experiments and was used to
normalize GPX1 mRNA expression. mRNA levels of GPX1 in both
whole blood and articular cartilage tissue in KBD group were lower
than that in control group (0.715- and 0.980-fold, respectively).
Results showed a signiﬁcant difference (P¼ 0.026) in whole blood
and no signiﬁcant difference in articular cartilage tissue (P¼ 0.780)
between the two groups (Fig. 3). GPX1 mRNA level showed noFig. 3. The GPX1 mRNA in whole blood and articular cartilage tissue. The GPX1 mRNA
level of whole blood was 0.715-fold lower in the KBD group than that in control group
(each n¼ 12, P¼ 0.026). But there was no signiﬁcant difference (P¼ 0.095) in articular
cartilage tissue between KBD (n¼ 9) and control group (n¼ 3). * represents signiﬁ-
cance at P< 0.05.signiﬁcant difference between subgroups of Pro/Leu, Leu/Leu and
Pro/Pro but it tended to decrease in individuals with Pro/Leu and
Leu/Leu (P> 0.05).
The mRNA expression of NF-kB p65 inwhole blood and articular
cartilage decreased in the KBD group compared to controls (0.403-
and 0.122-fold, respectively). Statistical analysis showed that both
differences are signiﬁcant [P< 0.001, (Fig. 4A)].
The mRNA level of p53 in whole blood and articular cartilage
tissue increased signiﬁcantly in the KBD group (3.922- and 7.357-
fold, respectively) compared to controls and the differences were
statistically signiﬁcant [P¼ 0.010 and 0.022, respectively, (Fig. 4B)].
Discussion
Epidemiological studies have shown that the distribution of
KBD overlaps the Se deﬁciency regions in China and KBD children
in endemic areas had lower Se in blood, urine and hair than that of
children free from this disease in endemic areas20e22. It is believed
that genetic factors as well as environmental Se deﬁciency
underlie the pathogenesis of KBD. GPX, TrxR, SEPP and DIO are
important antioxidative selenoproteins responsible for cell
growth, immune function and metabolism of bone. Furthermore,
one of the primary features of KBD is apoptosis and necrosis of
chondrocytes resulting from excessive oxidative stress. The genes
coding for these selenoproteins are getting more attention from
researchers. In recent years, possible associations between genetic
variations in these selenoprotein genes and risk of cancer,
cardiovascular disorder and other diseases have been stud-
ied16e19,23. The ﬁndings suggested some functional SNPs of sele-
noprotein genes were related with susceptibility to diseases, but it
is not known whether these genetic variations play a role in the
development of KBD.
To clarify whether polymorphisms in selenoproteins were
correlated with KBD risk we conducted a caseecontrol study to
investigate four genetic polymorphisms across selenoprotein
genes. These potential SNPs of the genes were GPX1 (rs1050450),
TrxR2 (rs5748469), SEPP1 (rs7579) and DIO2 (rs225014)24e26
which are all tag SNPs in coding regions. Genotype analysis was
performed using PCR-RFLP and ARMS-PCR. The two methods for
SNP typing are simple, low cost, label-free and reproducible.
Results showed that the genotypic and allelic frequency of GPX1
198Pro/Leu was statistically different between the KBD and control
groups (P¼ 0.016, 0.043, respectively), whereas no signiﬁcant
differences were found in the other three SNPs (Table IV). In the
four polymorphisms, the Pro198Leu variation of GPX1 was signif-
icantly associated with an increased risk of KBD.
In mammalian cells, GSH and GPX constitute the principal
antioxidant defense system27. There are at least six different GPX
isoenzymes in GPX family of which the most abundant is GPX1, an
intracellular Se-dependent antioxidant selenoenzyme within most
cells. The human GPX1 gene possesses several genetic poly-
morphisms, one of which, GPX1 Pro198Leu, is supposed to be
functional16,18,28 as the amino acid change from proline to leucine
at codon 198 may cause some important conformational changes
of GPX129. Interestingly, some epidemiologic studies indicated
that frequency of Leu allele of GPX1 was strongly associated with
an increased risk of various cancers30e33, though these correla-
tions have not been consistently observed in all populations34.
The current study showed that an increased risk of KBD was
observed in carriers of Pro/Leu and Leu/Leu compared with
homozygous wild-type (Pro/Pro) individuals (OR¼ 1.781; 95%CI:
1.127e2.814), and that GPX1 198Pro/Leu was associated with
increased KBD risk in a Chinese Han population. Correspondingly,
the Leu allele of the GPX1 polymorphism was correlated with
increased KBD risk (OR¼ 1.563; 95%CI: 1.025e2.385). It is
Fig. 4. The mRNA expression of NF-kB p65 and p53 in whole blood and articular cartilage tissue. (A) The mRNA expressions of NF-kB p65 in whole blood and articular cartilage
tissue decreased statistically in KBD group as compared with control group (0.403- and 0.122-fold, P< 0.001). (B) The mRNA level of p53 in whole blood and articular cartilage tissue
increased signiﬁcantly in the KBD group (3.922- and 7.357-fold, respectively) compared to control group and the differences were signiﬁcant by statistical analysis (P¼ 0.010 and
0.022). 12 KBD patients and 12 controls for whole blood, nine KBD patients and three controls for articular cartilage tissue. * represents signiﬁcance at P< 0.01.
Y.M. Xiong et al. / Osteoarthritis and Cartilage 18 (2010) 817e824822plausible that GPX1 Pro198Leu might be a genetic risk factor for
the development of KBD. In this study, no associations were found
between KBD risk and three other gene polymorphisms of TrxR2,
SEPP1 and DIO2.
We also investigated the GPX enzyme activity and mRNA
expression of GPX1. Results showed that GPX enzyme activity and
mRNA level inwhole blood were lower in the KBD group compared
with controls (both P< 0.01). No signiﬁcant difference was found in
the GPX1 mRNA expression in articular cartilage tissue between
KBD and control group which is in accordance with the results of
Wang et al.15. It is possible that functional polymorphisms in sele-
noprotein genes inﬂuenced selenoproteins expression, stability or
activity35. Ravn-Haren et al. reported that GPX1 Pro198Leu
genotype and GPX activity were strongly correlated and GPX
activity was lower in individuals with the variant T-allele29,32. In
our study, when subdivided by GPX1 Pro198Leu genotype, the GPX
activity in whole blood decreased signiﬁcantly in the subgroup of
individuals with Pro/Leu and Leu/Leu compared to Pro/Pro
(P< 0.01). This was in accordance with Ravn-Haren's results. GPX1
mRNA level was not signiﬁcantly different between subgroups of
Pro/Leu, Leu/Leu and Pro/Pro but tended to decrease in individuals
with Pro/Leu and Leu/Leu (data not shown).
Somewhat at potential variance with our results are the results
with the GPX1 knockout mice. These mice have no apparent oste-
oarthritis, as do KBD patients, but rather have an increased
susceptibility to paraquat and other oxidizing chemicals36. More
likely though, the GPX1 polymorphism observed here to be
correlated with KBD is coincident with some other defect, perhaps
by genetic linkage to a nearby gene or causes secondary effects
which are more directly related to pathogenesis. Reactive oxygen
species also serve as signaling molecules in cells and can affect
other cell signaling pathways.
Decreased GPX enzymic activity would unbalance the redox
system. Excessive oxidative stress could result in apoptosis and
necrosis of chondrocytes which could then play a crucial role in the
pathogenesis of KBD37,38. It is known that NF-kB p65 is an impor-
tant subunit of NF-kB which is a well-known transcription factor
family involved in the progress of inﬂammation and anti-apoptosis
and its inhibition would increase apoptosis39. p53 was reported to
play an important role in starting apoptosis and controlling thecellular response to DNA-damaging agents and mutation40.
Furthermore, p53 can be regulated by the NF-kB p6541. Excessive
peroxidates might lead to chondrocyte apoptosis and necrosis
which could be reﬂected by NF-kB p65 and p53 expression.
To understand the relevant molecular mechanism in development
of KBD we investigated mRNA expression of NF-kB p65 and p53 in
both whole blood and articular cartilage tissue from KBD and
control subjects. The mRNA level of NF-kB p65 was lower in whole
blood and articular cartilage tissue in KBD patients (P< 0.001),
whereas the mRNA level of p53 increased (P< 0.05). This suggests
that apoptosis signaling pathways were activated in KBD patients.
These results could be a further clue in elucidating the molecular
mechanism of KBD.
This was the ﬁrst study on the association between these four
SNPs and KBD risk and further research is needed to conﬁrm and
expand the present results. Our sample size is relatively small and
a larger sample study is needed to verify and reﬁne our conclusions.
In addition, studies on other genetic variations, SNPeSNP interac-
tions and gene function of selenoproteinwould also be beneﬁcial to
determine susceptibility genes of KBD.
In summary, results of our study demonstrated that Pro198Leu
of GPX1might be a genetic risk factor in the development of KBD. It
is indicated that GPX1 Leu allele might be associated with higher
KBD risk among Chinese Han population with lower GPX enzyme
activity. In addition, alteration of NF-kB p65 and p53 mRNA
expression suggests that apoptosis signaling might be activated in
KBD patients. This study is essential for elucidating the etiology and
pathogenesis of KBD and searching for new treatment targets for
KBD.
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